Uy Ear attributes the recent flattening in weekly prescription trends to temporary disruptions caused by hurricanes, rather than fundamental issues with the company’s products. The analyst remains ...
In addition, on 24 September, the NDA for vitiligo indication of ruxolitinib cream has been accepted by the National Medical Products Administration of China (NMPA). In accordance with the relevant ...
The US Department of Health and Human Services issued a new proposed rule Monday that would change how privacy protections for people with substance abuse disorders interact with HIPAA information ...